Figure 5
Compared the chemotherapy plus interval EGFR TKIs with TKIs monotherapy as the first-line treatment.
(A) OS; (B) ORR and DCR.
Figure 5 | Scientific Reports
Compared the chemotherapy plus interval EGFR TKIs with TKIs monotherapy as the first-line treatment.
(A) OS; (B) ORR and DCR.
